Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
34.4M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$782M
-
Value change
-
+$24.5M
-
Put/Call ratio
-
2.25
-
Number of buys
-
77
-
Number of sells
-
-87
-
Price
-
$22.75
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2018
231 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2018.
Editas Medicine, Inc. - Common Stock (EDIT) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.4M shares
of 82.8M outstanding shares and own 41.53% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (3.86M shares), BlackRock Inc. (3.68M shares), ARK Investment Management LLC (3.02M shares), STATE STREET CORP (2.15M shares), Capital World Investors (1.93M shares), MORGAN STANLEY (1.9M shares), FMR LLC (1.29M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares), CREDIT SUISSE AG/ (963K shares), and Viking Global Investors LP (931K shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.